Compare Opal Therapeutics vs Profectus BioSciences
Customers evaluate the quality of Opal Therapeutics's products using the following success metrics.
Overview
Opal Therapeutics is based in Australia
Opal Therapeutics is an immunotherapy company focused on therapies for human immunodeficiency virus (HIV) and Hepatitis C (HCV), based on technology from the University of Melbourne.
Profectus BioSciences is 21 yrs old and is based in United States.
Profectus Biosciences is a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases. The Company's name, Profectus, when translated from its Latin roots, means"to advance or improve". The Company's proof of concept target is human immunodeficiency virus (HIV) with an intermediate term focus on hepatitis C virus (HCV).
Demo Video
Leadership
Stephen Kent (Founder)
Jeffrey N Meshulam (President)
Investors
UniSeed, Alloy Ventures
Coalition for Epidemic Preparedness Innovations, U.S. Department of Health and Human Services
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Opal Therapeutics has not claimed their profile.
Work for Opal Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Opal Therapeutics?
Claim your profile now.
Information not available because Profectus BioSciences has not claimed their profile.
Work for Profectus BioSciences? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Profectus BioSciences?
Claim your profile now.